> If Novo Nordisk set its US prices for Wegovy to match the Danish price, spending to treat half of US adults with obesity would drop from $411 billion to $94.5

> If Novo Nordisk set its US prices for Wegovy to match the Danish price, spending to treat half of US adults with obesity would drop from $411 billion to $94.5 billion, a roughly $316.5 billion savings. The solution to the drug price crisis is for the US to stop subsidizing the rest of the developed world. The US should set a rule saying that it will not pay more than the price the drug company charges to any developed country.